She filed the note somewhere and forgot about it. Four years later, a fever on a Thursday. By Saturday morning she was in the intensive care unit with overwhelming post-splenectomy infection — OPSI — caused by Streptococcus pneumoniae septicemia. She survived. Barely. Her physicians in the ICU had never seen a case before. The warning on that forgotten note turned out not to be hypothetical.
The spleen is medicine’s most underappreciated organ. Nobody’s fascinated by it the way they’re fascinated by the heart or the brain — it’s never the star of anyone’s anatomy class. It sits quietly in the left upper abdomen, tucked under the ribcage, doing work that’s easy to overlook right up until it fails, or gets removed.
And then — sometimes — people die from its absence in ways nobody saw coming, because nobody fully understood what the spleen was doing in the first place.
This is the corrective. Anatomy and the full spectrum of function — immune surveillance, blood filtration, blood cell reservoir, iron recycling — plus the clinical consequences of spleen disease, enlargement, and removal. The spleen deserves better than the footnote it usually gets. The stakes of not understanding it are real, and Sandra is proof.
Anatomy and Structure: The Spleen’s Architecture
The adult spleen runs about 11 cm long, 7 cm wide, 4 cm thick — roughly fist-sized — and weighs between 150 and 200 grams. It sits in the left upper quadrant, shielded by the lower ribcage, wedged between the stomach in front and the left kidney behind, suspended by ligaments to both.
Its position between the ninth and eleventh ribs explains two things at once: why rib fractures in that region can lacerate it, and why splenic trauma ranks among the most common serious abdominal injuries in blunt trauma, motor vehicle accidents especially.
The internal architecture mirrors the organ’s several jobs. Functional tissue (parenchyma) splits into two compartments — red pulp and white pulp — separated by a marginal zone. Red pulp makes up roughly 75 percent of splenic volume and consists of venous sinuses and splenic cords (cords of Billroth).
Blood moves through this tissue slowly, in close contact with specialized macrophages — splenic macrophages, or histiocytes — that patrol for abnormal red blood cells, cellular debris, bacteria, anything that shouldn’t still be circulating.
White pulp shows up as pale nodules against the red background on a cross-section. It’s lymphoid tissue: T lymphocytes in the periarteriolar lymphoid sheath (PALS), B lymphocytes in lymphoid follicles. This is the spleen’s immune tissue, organized around central arterioles so that every volume of blood passing through comes into intimate contact with active lymphocytes.
The marginal zone — the interface between red and white pulp — matters enormously for defense against encapsulated bacteria. It contains unique marginal zone B cells built for rapid antibody responses to polysaccharide antigens.
And the blood supply is generous, almost disproportionately so: roughly 5 percent of cardiac output, several hundred milliliters a minute, funneled into a relatively small organ. That high flow rate is the whole point — every drop of blood in the body passes through the spleen multiple times a day, giving its macrophages continuous opportunity to survey what’s circulating and remove what doesn’t belong.
Blood Filtration: The Splenic Police Force
The spleen’s most basic job is physical and immunological filtration — a continuous surveillance operation removing old, damaged, or abnormal cells and foreign material from circulation. Most of this happens in the red pulp, where blood squeezes through sinusoidal passages too narrow for abnormal red cells to pass easily.
Normal red blood cells run 6-8 micrometers in diameter but are biconcave, deformable discs able to squeeze through passages as narrow as 3-4 micrometers. Old cells — those nearing the end of their 120-day lifespan — get progressively stiffer as oxidative damage accumulates in their membrane proteins.
Those aged, rigid cells can’t make it through the splenic sinusoids. They get detained in the red pulp, where splenic macrophages recognize the surface changes marking them for removal. The macrophages engulf and digest them, pulling the iron out of hemoglobin for recycling and returning it to circulation via transferrin, where it goes back into new red cell production.
There’s also a process called “pitting,” which is the spleen’s way of culling abnormal inclusions from cells that are otherwise still viable. Red cells carrying nuclear remnants (Howell-Jolly bodies), iron granules (Pappenheimer bodies), or other inclusions pass through the splenic sinusoids in a way that strips out the inclusion while leaving the rest of the cell intact — the cell squeezes through a narrow gap, the rigid inclusion gets left behind. Elegant mechanical filtration, at the cellular level.
After splenectomy, Howell-Jolly bodies start showing up in circulating red cells on the peripheral blood smear. Their presence is a reliable marker of absent splenic function.
Beyond red cells, splenic macrophages clear platelets past their normal lifespan (roughly 7-10 days), circulating immune complexes, cellular debris — and, critically, bacteria. In septicemia, splenic filtration helps clear organisms from the blood and gives the immune response room to contain the infection. That bactericidal function is essential for surviving certain bacterial infections, which is exactly what Sandra’s case illustrates.
The Immunological Powerhouse: How the Spleen Fights Infection
The spleen’s immune functions make it the largest secondary lymphoid organ in the body — bigger than any lymph node, processing more antigen than any other single immune tissue. It runs both innate and adaptive immune operations, and its unusual vascular architecture puts blood-borne pathogens and antigens in immediate contact with the right immune cells.
Its particular importance shows up in defense against encapsulated bacteria — Streptococcus pneumoniae, Haemophilus influenzae type b, Neisseria meningitidis — organisms that wrap themselves in polysaccharide capsules to block phagocytosis by ordinary macrophages, absent specific antibodies (opsonins). These bacteria shrug off the complement-mediated and cellular mechanisms that handle most other infections; they need opsonization with specific IgM antibodies before phagocytosis can work.
The spleen’s marginal zone B cells are uniquely built for rapid IgM production against these polysaccharide antigens — they mount a protective antibody response far faster than conventional B cells, which need T cell help first.
The spleen is also the primary site of antibody production during the early phase of systemic infection, before memory B cells in lymph nodes and bone marrow have fully mobilized. Splenic B cells produce the first wave of IgM antibodies — the earliest antibody class after antigen exposure — coating bacteria and boosting their phagocytosis by macrophages throughout the body (opsonophagocytosis).
That early IgM response matters most in the first 24 to 72 hours — the window before the rest of the adaptive immune system is fully mobilized.
The spleen also holds a large population of T lymphocytes and natural killer (NK) cells involved in cell-mediated immunity against viral infections and intracellular parasites. Splenic T cells contribute to the immune response against malaria — the spleen is a major site of parasite-infected red cell destruction there — and losing that tissue through splenectomy raises malaria susceptibility in endemic regions.
The back-and-forth between splenic function and malaria resistance has been a significant evolutionary force, shaping both splenic immunity and the human immune response to Plasmodium falciparum.
The Reservoir Function and Hematopoiesis
In humans the reservoir function is more modest — the human spleen stores only about 30-40 mL of red blood cells at baseline — though there’s some evidence of splenic mobilization under extreme physiological stress. It’s a more significant reservoir for platelets (holding roughly 30 percent of the total platelet pool) and monocytes.
A 2017 study in Nature Communications documented a large reservoir of classical monocytes in the human spleen — the circulating precursors to tissue macrophages — that get mobilized to sites of injury or inflammation. After myocardial infarction, in both mice and humans, splenic monocytes flood the infarcted myocardium and take part in the inflammatory and repair process there.
Which revealed an unsuspected role: the spleen as a “monocyte reservoir” for deploying inflammatory response — a finding with real potential for post-infarction care and wound-healing biology.
The spleen can also perform extramedullary hematopoiesis — blood cell production outside the bone marrow. In the fetus, it’s an important production site (alongside the liver) during the second trimester. In adults, this isn’t normal splenic activity, but it switches on when bone marrow production is overwhelmed or compromised.
Chronic bone marrow failure (myelofibrosis), severe hemolytic anemia with heavy red cell destruction, and certain storage disorders (Gaucher disease, thalassemia) all trigger extramedullary hematopoiesis in the spleen as compensatory production. It’s one way the spleen can enlarge dramatically in certain hematological conditions.
There’s also an iron-homeostasis role that goes beyond simply recycling iron from destroyed red cells. Splenic macrophages hold major stores of the body’s total iron, sequestered as ferritin and hemosiderin. In iron overload states (hereditary hemochromatosis, transfusion-related overload, thalassemia), the spleen accumulates excess iron. In iron deficiency anemia with high erythropoietic demand, splenic macrophages release their stored iron to support red cell production.
The spleen, in that sense, is a dynamic iron reserve — buffering supply and demand across physiological states.
Splenomegaly: When the Spleen Grows Dangerous
Splenomegaly — pathological splenic enlargement — is one of medicine’s most diagnostically rich physical findings, because the differential diagnosis spans a remarkable range of conditions. A palpable spleen (normally it isn’t palpable at all) demands explanation, and the explanation often reveals critical information about an underlying systemic condition.
The causes are typically grouped by mechanism. Congestive splenomegaly comes from increased portal venous pressure backing up into the splenic vein, causing progressive enlargement. Liver cirrhosis is by far the most common cause, followed by portal vein thrombosis and hepatic vein thrombosis (Budd-Chiari syndrome).
In cirrhosis-related splenomegaly, the enlarged spleen sequesters increasing numbers of blood cells — hypersplenism, with low white cell count, low platelet count, sometimes anemia — and the resulting thrombocytopenia can become clinically significant, complicating both bleeding risk and treatment planning.
Infectious splenomegaly shows up across multiple infection categories. Infectious mononucleosis — Epstein-Barr virus in adolescents and young adults — characteristically causes tender splenomegaly in 50 to 75 percent of cases, and the risk of splenic rupture (rare, but potentially life-threatening) is the basis for the standard advice against contact sports for 3-4 weeks after diagnosis.
Malaria, acute and chronic, is a major cause of tropical splenomegaly — the “big spleen disease” of endemic regions, where chronic exposure drives persistent enlargement. Visceral leishmaniasis (kala-azar) causes some of the most dramatic splenomegaly seen in clinical medicine, sometimes stretching the spleen down to the pelvis.
Hematological malignancies — lymphomas, leukemias, myeloproliferative disorders — are the most important cause of massive splenomegaly in developed countries, and always sit on the differential for unexplained enlargement. Chronic myeloid leukemia (CML) classically presents with a massively enlarged spleen; it can extend well below the umbilicus and weigh several kilograms in advanced cases.
Myelofibrosis produces the most extreme splenomegaly of any condition, the spleen compensating for the bone marrow’s progressive failure through extramedullary hematopoiesis.
Storage diseases — enzyme deficiencies that let substrates accumulate inside cells — hit the spleen especially hard because its abundant macrophage population is the primary site of that accumulation. Gaucher disease (glucocerebrosidase deficiency, the most common lysosomal storage disorder) classically causes hepatosplenomegaly, anemia, thrombocytopenia, and bone disease. Niemann-Pick disease, Fabry disease, and the mucopolysaccharidoses affect the spleen in similar ways.
Enzyme replacement therapy for Gaucher disease has transformed its management and demonstrated something useful in general: reduce the splenic macrophage substrate burden, and spleen size and hematological function can dramatically improve.
Hypersplenism: The Spleen Eating Its Own
Hypersplenism is a clinical syndrome of excessive blood cell sequestration and destruction by an enlarged spleen, producing cytopenias — reductions in one or more blood cell lines — that don’t reflect inadequate bone marrow production. The term captures the idea of the spleen overperforming its filtering job, to the detriment of circulating blood cell counts.
The typical picture: thrombocytopenia, leukopenia, and varying degrees of anemia, in a patient with a palpably enlarged spleen and some underlying cause for that enlargement. The bone marrow in hypersplenism is hyperactive, working overtime to replace what the spleen is sequestering — an important diagnostic clue distinguishing hypersplenism from primary bone marrow failure.
Bone marrow biopsy showing hypercellularity (increased production) rather than hypocellularity (reduced production), against a backdrop of peripheral cytopenias, points toward spleen-mediated destruction rather than a production problem.
Clinically significant hypersplenism — platelet counts low enough to raise bleeding risk, or white cell counts low enough to meaningfully impair immune defense — may call for intervention. Options include treating the underlying cause (reducing portal hypertension in cirrhosis, chemotherapy for malignancy), splenic irradiation (partial ablation that reduces sequestration while preserving some splenic immune function), or splenectomy.
Not a simple call. Splenectomy removes the sequestration problem but creates the lifetime infection risk of the asplenic state, and the underlying condition — usually cirrhosis or malignancy — still has to be weighed into the risk-benefit calculation.
Splenic Rupture: The Surgical Emergency
Kehr’s sign — left shoulder tip pain from diaphragmatic irritation by blood pooling under the left hemidiaphragm — is a classic finding, though not a sensitive one.
Splenic trauma management has shifted dramatically over the past thirty years, from mandatory splenectomy to selective non-operative management (NOM). The AAST (American Association for the Surgery of Trauma) grading scale runs from Grade I (minor subcapsular hematoma) to Grade V (complete shatter or hilar devascularization), and stable patients with Grade I-III injuries are now routinely managed without surgery at trauma centers experienced with NOM.
Angioembolization — catheter-directed occlusion of bleeding splenic arterial branches — has widened the range of injuries manageable without open surgery. The goal, wherever possible, is splenic preservation: keep the immune function, avoid the lifelong OPSI risk of going asplenic.
Spontaneous splenic rupture — no trauma involved — is rare but well documented in conditions that cause rapid splenic enlargement: infectious mononucleosis (the most common association with spontaneous rupture in otherwise healthy young people), malaria, certain lymphomas or leukemias. It’s why contact sports get restricted for 3-4 weeks after a mono diagnosis — the enlarged, friable spleen is vulnerable to rupture from deceleration or contact forces that a normal spleen would shrug off.
Cases of splenic rupture from EBV infection while simply coughing, or defecating, have been documented.
Post-Splenectomy: Living Without a Spleen
Splenectomy gets performed for a range of indications: traumatic rupture, immune thrombocytopenic purpura (ITP) unresponsive to medical management, hereditary spherocytosis, certain lymphomas, splenic abscess, and — historically, though largely replaced now by PET-CT imaging — staging surgery for Hodgkin lymphoma. In every case, the surgery solves the immediate problem while creating a permanent immunological vulnerability that demands lifelong attention.
Overwhelming post-splenectomy infection (OPSI) is the most feared late complication. OPSI means severe septicemia — typically from encapsulated bacteria — in a patient without a spleen, and it carries a mortality rate of 50 to 70 percent even with appropriate antibiotic treatment. The syndrome starts with a prodrome of fever and malaise, then progresses with alarming speed to fulminant septic shock and DIC (disseminated intravascular coagulation) within hours.
The speed is what kills. By the time a treating physician recognizes the severity, the patient may already be in irreversible shock. OPSI typically strikes within the first two years post-splenectomy but can show up decades later — the lifetime risk never hits zero.
The pathogens responsible — Streptococcus pneumoniae, Haemophilus influenzae type b, Neisseria meningitidis — are the same encapsulated bacteria that need splenic marginal zone B cell-mediated opsonization for effective clearance. Without the spleen’s unique IgM response to polysaccharide capsules, organisms present in low numbers can multiply to fatal concentrations faster than the adaptive immune response can keep up.
Preventing OPSI requires three coordinated pieces. First, vaccination: everyone undergoing elective splenectomy should get the pneumococcal polysaccharide vaccine (PPSV23) or conjugate vaccine (PCV20/PCV15), the Haemophilus influenzae type b (Hib) vaccine, and meningococcal vaccine (conjugate and serogroup B where available), at least two weeks before surgery so antibodies can develop with a still-functioning spleen. Vaccination after splenectomy is less immunogenic.
Second, antibiotic prophylaxis: many guidelines recommend prophylactic penicillin or amoxicillin for two to five years post-splenectomy at minimum — some recommend lifelong prophylaxis, particularly for high-risk groups: children, patients with hematological malignancy, anyone splenectomized in the first year of life.
Third, patient education. People need to understand the OPSI risk, know to seek immediate care at the first sign of fever (above 38°C), carry a prescription for emergency antibiotics to start before reaching medical care, and carry documentation of their asplenic status. All three pieces matter. Skip one and the other two do less work than they should.
Splenic Conditions Requiring Specific Attention
Beyond the major categories — splenomegaly, hypersplenism, trauma — several specific splenic conditions deserve their own attention for what they signal. Splenic infarction, ischemic death of splenic tissue, typically presents as acute left upper quadrant pain and shows up on contrast CT as wedge-shaped areas of non-enhancement in the splenic parenchyma.
Causes include embolism (from left-sided cardiac sources, atrial fibrillation especially), hypercoagulable states (antiphospholipid syndrome, sickle cell disease), vascular compression from adjacent masses, and extreme splenomegaly reducing blood flow to the periphery. Most splenic infarcts are managed conservatively.
Splenic abscess is rare but dangerous, usually developing through hematogenous seeding from bacteremia or direct spread from a nearby infection. Endocarditis is a classic setting — septic emboli from infected cardiac valves lodge in the spleen and form abscesses. CT shows low-density lesions with surrounding enhancement; the clinical picture combines left upper quadrant pain, fever, and the context of the underlying infection.
Management typically means drainage (percutaneous or surgical) plus prolonged antibiotics; splenectomy may be needed for multiple or large abscesses.
Splenic cysts can be congenital (epithelial-lined, developmental) or parasitic — echinococcal cysts (from Echinococcus granulosus, the dog tapeworm) are the most important parasitic lesions, endemic in sheep-farming regions, capable of growing into large, complex cystic lesions that can rupture and cause anaphylaxis or secondary seeding. The characteristic CT and serological findings of echinococcosis call for specific treatment — albendazole plus PAIR (Puncture, Aspiration, Injection of scolicidal agent, Reaspiration) or surgery — rather than simple cyst drainage.
Splenic vein thrombosis — isolated thrombosis of the splenic vein without portal vein involvement — is an underrecognized cause of left-sided portal hypertension and isolated gastric varices. Pancreatitis, particularly chronic pancreatitis with local inflammation and compression, is the most common cause. Patients present with gastrointestinal bleeding from gastric fundal varices, or unexplained splenomegaly. Diagnosis needs CT venography or MRI angiography to visualize the splenic vein.
Splenectomy — which removes the source of increased flow into the obstructed vein — is the definitive treatment for symptomatic cases with meaningful bleeding risk.
The Spleen and Autoimmune Disease
Immune thrombocytopenic purpura (ITP) is the autoimmune condition most classically treated by splenectomy. In ITP, autoantibodies — typically IgG against platelet surface glycoproteins — coat platelets, marking them for destruction by splenic macrophages. The spleen ends up being both the primary site of antiplatelet antibody production (by splenic B cells) and the primary site of antibody-coated platelet destruction (by splenic macrophages) — the source and the executioner in the same organ.
Splenectomy removes both populations at once, producing remission in roughly two-thirds of patients with chronic ITP who’ve failed first-line treatment. The remaining third either have autoantibody production continuing in other lymphoid tissue (bone marrow, lymph nodes), or accessory spleens that weren’t removed during the original procedure.
Autoimmune hemolytic anemia (AIHA) — antibody-mediated red cell destruction — similarly uses the spleen as a primary destruction site for antibody-coated red cells. Warm AIHA (IgG-mediated, the more common form) responds to splenectomy in a majority of cases, because warm IgG antibodies direct destruction mostly to the spleen rather than the liver.
Cold AIHA (IgM-mediated) responds less well to splenectomy, because the complement activation triggered by IgM antibodies directs destruction to Kupffer cells in the liver instead.
Systemic lupus erythematosus (SLE) affects the spleen in its own characteristic ways. Libman-Sacks endocarditis (valvular vegetations) in SLE can send emboli to the spleen. “Onion skin” fibrosis around penicilliary arteries — a pattern of periarteriolar fibrosis — is a pathognomonic histological finding of SLE in the spleen. Hyposplenism (reduced function despite a present spleen) can occur in SLE from infarction or fibrosis, adding OPSI-like infection risk without the clinical trigger of splenectomy that would normally prompt appropriate prophylaxis.
Supporting Splenic Health: What the Evidence Shows
Unlike most organs with specific disease states tied to specific modifiable risk factors, splenic health mostly follows the health of the broader systems it serves — the immune system, the portal circulation, the hematological system. There’s no “splenic health diet,” no dedicated exercise protocol, not the way there is for the heart.
But the factors that support overall immune function, cut chronic inflammation, and keep portal blood flow healthy are the same factors that support the spleen.
Excessive alcohol damages it through multiple routes. Acute alcohol exposure impairs splenic neutrophil and macrophage function, cutting bactericidal activity in the red pulp. Chronic abuse causes liver cirrhosis, which creates portal hypertension and congestive splenomegaly with progressive hypersplenism. Alcohol also impairs splenic B cell function and reduces the antibody response to polysaccharide vaccines — a clinically relevant interaction when immunizing patients with alcohol use disorder.
Maintaining healthy body weight and metabolic function preserves portal blood flow dynamics and heads off the cirrhosis-related portal hypertension that’s the most common cause of congestive splenomegaly in developed countries. Non-alcoholic fatty liver disease (NAFLD) progressing to non-alcoholic steatohepatitis (NASH) and cirrhosis is an increasingly common cause of portal hypertension and splenomegaly — directly modifiable through weight management and metabolic health.
Vitamin D plays an underappreciated role in splenic immune function. Splenic macrophages and lymphocytes express vitamin D receptors, and deficiency impairs splenic macrophage bactericidal function and reduces immunoglobulin production by splenic B cells. Population studies consistently show an inverse relationship between vitamin D status and susceptibility to exactly the encapsulated bacterial infections the spleen is tasked with controlling.
Direct evidence that supplementation improves splenic function is limited. Still, the mechanism and the observational data support maintaining adequate vitamin D status as part of overall immune health.
Anatomy Structure Spleens Q&A About the Spleen
Can you live a normal life without a spleen?
Most people live normal, full lives after splenectomy — but not without attention to the specific risks of asplenic living.
The critical requirements: vaccination against encapsulated bacteria (pneumococcus, Haemophilus influenzae b, meningococcus) with maintained vaccine currency through boosters; consideration of antibiotic prophylaxis, particularly for the first two to five years and in high-risk individuals; immediate medical evaluation for any fever above 38°C regardless of how well the patient otherwise feels; and carrying documentation of asplenic status for any emergency medical encounter.
People who follow these precautions live essentially normal lives. People who don’t are exposed to a real, and preventable, risk of fatal sepsis.
What causes sudden left upper quadrant pain?
Sudden left upper quadrant pain has a broad differential, but the spleen is always on it. Splenic infarction (from emboli or thrombosis) presents as sharp left upper quadrant pain, often pleuritic if the upper pole is involved. Splenic rupture presents as more severe pain, potentially with hemodynamic compromise. Splenic abscess brings pain with fever. Splenic cyst rupture or hemorrhage is less common but dramatic when it happens.
Non-splenic causes include pancreatitis (which can mimic splenic pain), left kidney pathology, gastric pathology, and left lower lobe pneumonia with pleuritis. Contrast CT is the most informative imaging study for sorting these out.
Is an enlarged spleen dangerous?
An enlarged spleen is always diagnostically significant and always demands explanation — it doesn’t just happen without a cause. Danger depends on cause and severity. The most acute risk is rupture — an enlarged, friable spleen (infectious mononucleosis in particular) is more vulnerable to rupture from relatively minor trauma. Hypersplenism from a massively enlarged spleen creates cytopenias that can raise bleeding risk or infection susceptibility.
The bigger concern, though, is identifying the underlying condition driving the splenomegaly, which can range from treatable infection to lymphoma to cirrhosis — each needing its own specific management.
Does the spleen regenerate after partial splenectomy or injury?
Not the way liver tissue regenerates after partial resection. But “splenosis” can occur — fragments of splenic tissue seeded into the peritoneal cavity during traumatic rupture or partial splenectomy can implant on peritoneal surfaces and grow into functional, if small, splenic tissue. These implants show up on nuclear medicine imaging (heat-damaged red cell scintigraphy) and may provide partial immune function, lowering — though not eliminating — OPSI risk compared to complete functional asplenia.
Accessory spleens — congenital secondary splenic tissue present in roughly 10-15 percent of people — may also provide partial splenic function after splenectomy, if they weren’t removed along with the main organ.
What blood test abnormalities suggest poor splenic function?
The peripheral blood smear is the most direct evidence. Howell-Jolly bodies — dark-staining nuclear remnants in red blood cells — appear after splenectomy or in functional asplenia (as in sickle cell disease with autosplenectomy), where they’d normally be removed by splenic pitting. Target cells, acanthocytes, and siderocytes (Pappenheimer bodies) may also show up. Thrombocytosis (elevated platelet count) is common after splenectomy, since the spleen normally sequesters 30 percent of the platelet pool.
Leukocytosis, monocytosis in particular, can also occur. A complete blood count with differential and peripheral smear review gives a functional read on splenic activity without needing imaging at all.
The Spleen in Sickle Cell Disease: A Systematic Organ Failure
Sickle cell disease is one of medicine’s most instructive examples of progressive organ failure from repeated vascular insults, and the spleen is usually the first major organ to go. In homozygous sickle cell disease (HbSS), structurally abnormal hemoglobin polymerizes under deoxygenated conditions, forcing red cells into the characteristic rigid, sickled shape that obstructs the microvasculature. The spleen, with its dense network of narrow sinusoidal passages, is particularly exposed to vascular occlusion by sickled cells.
In infancy and early childhood, children with sickle cell disease have an enlarged, functioning spleen — the high-flow, low-oxygen environment there is initially a site where sickling happens frequently, causing episodic acute splenic sequestration crises: sudden trapping of large blood volumes in the spleen, producing acute severe anemia and splenomegaly that can trigger hemodynamic collapse.
These sequestration crises are among the most dangerous early complications of sickle cell disease and were, historically, a leading cause of death in young children before management improved. Emergency red cell transfusion can reverse the acute crisis, and splenectomy or hydroxyurea therapy to cut sequestration risk is often recommended after a severe episode.
The chronic, cumulative damage from repeated vascular occlusion progressively destroys the splenic parenchyma through infarction. By early adulthood, most patients with HbSS have undergone “autosplenectomy” — the spleen progressively infarcted down to a small, fibrotic, non-functional remnant, sometimes visible on imaging as a calcified “eggshell” of former splenic tissue.
This functional asplenia creates exactly the same OPSI risk as surgical splenectomy — but without the clinical trigger of surgery to prompt appropriate prophylaxis. Historically, septicemia from S. pneumoniae was a leading cause of death in children with sickle cell disease, before penicillin prophylaxis and pneumococcal vaccination became standard — a demonstration, if one was needed, of just how lethal unprotected functional asplenia can be in a vulnerable population.
The Practical Framework: Applying Anatomy Structure Spleens Architecture In Real Life
References
- Research on Anatomy Structure: (PubMed)
- NIAID Immune System Research
- MedlinePlus: Anatomy Structure: